Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Orgenesis Inc
ORGS | US
0.49
USD0.48
4.85K%
ORGS | US
About Orgenesis Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
0.49
Open
0.40
High
0.49
Low
0.40
Orgenesis Inc. a biotech company focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown Maryland.
View LessORGS | US
Risk
29690.8
Sharpe
-0.00
Luna's Score
51/100
Recommendation
Hold
Luna says (ORGS | US)
What's Working
Positive Momentum
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
38738.4%1 month
29690.8%3 months
16701.2%6 months
12345.4%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.26
Debt to equity
-0.84
Debt to assets
0.43
Ent. to EBITDA
-4.98
Ent. to rev.
42.89
PEG
-
Other Fundamentals
EBITDA
-19.06M
MarketCap
2.36M
MarketCap(USD)
2.36M
Div. yield
-
Op. margin
-1.65K
Erngs. growth
-
Rev. growth
117.70
Ret. on equity
-727.25
Short ratio
2.39
Short perc.
1.33
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.58
Range1M
0.84
Range3M
0.84
Volumes: Market Activity
Rel. volume
0.11
Price X volume
128.21
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -4.98 | - | Cheaper |
| Ent. to Revenue | 42.89 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.26 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 16,701.20 | - | Riskier |
| Debt to Equity | -0.84 | -1.23 | Expensive |
| Debt to Assets | 0.43 | 0.25 | Expensive |
| Market Cap | 2.36M | - | Emerging |
